Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
PLoS One. 2013;8(3):e59302. doi: 10.1371/journal.pone.0059302. Epub 2013 Mar 15.
To investigate whether T-cell activation and exhaustion is linked to HCV- and HIV disease parameters in HIV/HCV infected individuals, we studied T-cell characteristics in HIV/HCV coinfected patients and controls.
14 HIV/HCV coinfected, 19 HCV monoinfected, 10 HIV monoinfected patients and 15 healthy controls were included in this cross-sectional study. Differences in expression of activation and exhaustion markers (HLA-DR, CD38, PD-1, Tim-3 and Fas) and phenotypic markers on CD4(+) and CD8(+) T-cells were analysed by flow cytometry and were related to HCV disease parameters (HCV-viremia, ALT and liver fibrosis).
Frequencies of activated CD4(+) and CD8(+) T-cells were higher in HIV/HCV-coinfected compared to healthy controls and HCV or HIV mono-infected individuals. Coinfected patients also showed high expression of the exhaustion marker PD-1 and death receptor Fas. In contrast, the exhaustion marker Tim-3 was only elevated in HIV-monoinfected patients. T-cell activation and exhaustion were correlated with HCV-RNA, suggesting that viral antigen influences T-cell activation and exhaustion. Interestingly, increased percentages of effector CD8(+) T-cells were found in patients with severe (F3-F4) liver fibrosis compared to those with no to minimal fibrosis (F0-F2).
HIV/HCV coinfected patients display a high level of T-cell activation and exhaustion in the peripheral blood. Our data suggest that T-cell activation and exhaustion are influenced by the level of HCV viremia. Furthermore, high percentages of cytotoxic/effector CD8(+) T-cells are associated with liver fibrosis in both HCV monoinfected and HIV/HCV coinfected patients.
为了探究 T 细胞的激活和耗竭是否与 HIV/HCV 感染者的 HCV 和 HIV 疾病参数有关,我们研究了 HIV/HCV 合并感染患者和对照组的 T 细胞特征。
本横断面研究纳入了 14 例 HIV/HCV 合并感染、19 例 HCV 单感染、10 例 HIV 单感染患者和 15 例健康对照者。通过流式细胞术分析 CD4(+)和 CD8(+)T 细胞上的激活和耗竭标志物(HLA-DR、CD38、PD-1、Tim-3 和 Fas)以及表型标志物的表达差异,并将其与 HCV 疾病参数(HCV 病毒血症、ALT 和肝纤维化)相关联。
与健康对照组和 HCV 或 HIV 单感染个体相比,HIV/HCV 合并感染患者的 CD4(+)和 CD8(+)T 细胞的激活频率更高。合并感染患者还表现出高水平的耗竭标志物 PD-1 和死亡受体 Fas。相比之下,耗竭标志物 Tim-3 仅在 HIV 单感染患者中升高。T 细胞的激活和耗竭与 HCV-RNA 相关,提示病毒抗原影响 T 细胞的激活和耗竭。有趣的是,在肝纤维化严重(F3-F4)的患者中,效应 CD8(+)T 细胞的百分比增加,与无至最小纤维化(F0-F2)的患者相比。
HIV/HCV 合并感染患者的外周血中存在高水平的 T 细胞激活和耗竭。我们的数据表明,T 细胞的激活和耗竭受到 HCV 病毒血症水平的影响。此外,在 HCV 单感染和 HIV/HCV 合并感染患者中,高比例的细胞毒性/效应 CD8(+)T 细胞与肝纤维化相关。